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Abstract
Immunization with radiation (c)-attenuated Plasmodia sporozoites (c-spz) confers sterile and long-lasting immunity against
malaria liver-stage infection. In the P. berghei c-spz model, protection is linked to liver CD8
+ T cells that express an effector/
memory (TEM) phenotype, (CD44
hiCD45RB
loCD62L
lo ), and produce IFN-c. However, neither the antigen presenting cells
(APC) that activate these CD8
+ TEM cells nor the site of their induction have been fully investigated. Because conventional
(c)CD8a
+ DC (a subset of CD11c
+ DC) are considered the major inducers of CD8
+ T cells, in this study we focused primarily
on cCD8a
+ DC from livers of mice immunized with Pb c-spz and asked whether the cCD8a
+ DC might be involved in the
activation of CD8
+ TEM cells. We demonstrate that multiple exposures of mice to Pb c-spz lead to a progressive and nearly
concurrent accumulation in the liver but not the spleen of both the CD11c
+NK1.1
2 DC and CD8
+ TEM cells. Upon adoptive
transfer, liver CD11c
+NK1.1
2 DC from Pb c-spz-immunized mice induced protective immunity against sporozoite challenge.
Moreover, in an in vitro system, liver cCD8a
+ DC induced naı ¨ve CD8
+ T cells to express the CD8
+ TEM phenotype and to
secrete IFN-c. The in vitro induction of functional CD8
+ TEM cells by cCD8a
+ DC was inhibited by anti-MHC class I and anti-IL-
12 mAbs. These data suggest that liver cCD8a
+ DC present liver-stage antigens to activate CD8
+ TEM cells, the pre-eminent
effectors against pre-erythrocytic malaria. These results provide important implications towards a design of anti-malaria
vaccines.
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Introduction
Dendritic cells (DC) are key conductors in the orchestration of
the immune responses to a variety of pathogens [1]. A number of
DC subsets have been identified, including conventional
(c)CD8a
+DC, cCD8a
2DC and plasmacytoid (p)DC and these
appear to perform unique functional activities. For example,
cCD8a
+ DC efficiently cross present cell-associated Ags particu-
larly to CD8
+ T cells [2,3]; cCD8a
2 DC usually promote the
activation of CD4
+ T cells [4]; and pDC tend to respond to viral
infections [5] and may be involved in the activation of Treg cells
[6]. In addition, the distribution of the DC subsets is unique for
lymphoid and non-lymphoid organs [7,8] and this can lead to an
organ-specific response often dictated by the tropism of infectious
agents. Owing to their prominent role in directing the immune
system, DC have been shown to be indispensable for the induction
of protective immune responses to a variety of infections [9] ,
including malaria that is caused by Plasmodia ssp. infected
mosquitoes.
Prime-boost immunizations with radiation-attenuated (c) Plas-
modia sporozoites (c-spz) constitutes the most effective method for
inducing long-lived, sterile protection against the pre-erythrocytic
stages (sporozoite and liver) of both rodent and human malaria
[10,11]. We have reported that Plasmodium berghei (Pb) c-spz-
induced protection against liver-stage infection is mediated
primarily by intrahepatic IFN-c-producing effector/memory
CD44
hiCD45RB
loCD62L
lo CD8
+T cells (CD8
+TEM) [12]. How-
ever, the mechanisms of activation of intrahepatic CD8
+TEM cells
require further investigation. For example, the identity of the APC
that process and present liver-stage Ags for the induction of the
CD8
+TEM cells remains to be elucidated. Several studies
conducted in the past have revealed a critical role for DC in the
induction of anti-Plasmodia protection against pre-erythrocytic
stage Ags. It has been demonstrated that DC-depleted mice fail to
develop protection following c-spz immunization [13]. Bone-
marrow derived dendritic cells pulsed with Pb c-spz or Pb-derived
antigen induced antigen-specific CD8
+ T cell responses [14].
Similary, adoptive-transfer of DC loaded with Plasmodium yoelii (Py)
circumsporozoite (CS) protein peptides into BALB/c mice results
in the generation of peptide-specific CD8
+ T cells and reduction of
parasitemia following infectious challenge [15]. More recently, it
has been shown that DC prime Py CS protein specific TCR Tg
CD8
+ T cells in the LN draining the site of the mosquito bite,
however, the CD8
+ T cell effector function following infectious
sporozoite challenge occurs in the liver and is DC independent
[16]. These and other studies comprise a significant body of work
on the roles of splenic [17,18] and bone marrow-derived DC
[19,20] but comparable studies of liver DC have not been carried
out, in part because of the paucity of these cells. Nonetheless, liver
DC have been shown to play an important role in liver immunity
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to the liver stage of malaria remains unknown and, hence, requires
investigation. In addition, the relative contributions of the various
liver DC subsets also remain to be elucidated. Like infectious spz,
Pb c-spz infect hepatocytes but the parasites arrest at the liver-
stage of development, which leads to the apoptosis of the infected
hepatocytes [22]. In contrast, infectious sporozoites do not cause
infected hepatocytes to undergo apoptosis and are ineffective in
inducing protective CD8
+ T cells [23,24]. Because numerous
studies [2,3,25,26] have shown that cCD8a
+ DC in particular can
ingest exogenous cell-associated Ag and cross-present it to CD8
+ T
cells, it is reasonable to assume, therefore, that c-spz-induced
apoptotic hepatocytes are internalized by hepatic DC [22] and the
available liver-stage Ags are cross-presented to hepatic CD8
+ T
cells. We asked therefore whether the cCD8a
+ subset of liver DC is
involved in the induction of the effector CD8
+ T cells that mediate
protection against Pb sporozoite challenge.
Herein, we present evidence that cCD8a
+DC accumulate
concurrently with CD8
+ TEM cells in the livers of Pb c-spz-
immunized mice. We also show that these cells are able to activate
naı ¨ve CD8
+T cells to express the TEM phenotype (CD44
hiCD45R-
B
loCD62L
lo). Therefore, we propose that cCD8a
+DC are involved
in the induction of the liver-stage antigen-specific CD8
+ T cells,
the key effectors against liver-stage malaria.
Results
The numbers of CD11c
+NK1.1
2 DC are low in the livers of
naı ¨ve mice, but increase following prime-boost
immunizations with Pb c2spz
Liver CD8
+ T cells are the key effectors in protection induced
by Pb c2 spz [27]; however, neither the cellular/molecular
processes leading to the induction of these cells nor the sites where
this induction occurs have been thoroughly investigated. For
example, it is not fully understood whether DC and/or other APC
are involved in the presentation of liver-stage Ags for the activation
of CD8
+ T cells. Because c-spz enter hepatocytes, where they
undergo an aborted development, it is reasonable to assume that
Ags responsible for the induction of effector CD8
+ T cells are
expressed primarily in the liver [28]. Because DC are considered
the most efficient professional APC, we presumed, therefore, that
liver DC might be excellent APC candidates for presentation of
liver-stage Ags to CD8
+ T cells.
For the initial experiments we used flow cytometry to identify a
population of CD11c
+NK1.1
2 DC in the liver and the spleen
according to the gating strategy shown in Fig. 1A and Fig. 2A. To
exclude all T cells and in particular CD8
+ T cells (expressing
CD8ab dimers) as well as NK cells, intrahepatic mononuclear cells
(IHMNC) and spleen cells were stained with anti-CD3/CD8b and
anti-CD11c mAbs and the CD11c
+CD3
2CD8b
2 population was
further subdivided based on the expression of NK1.1 into
CD11c
+NK1.1
2 DC and CD11c
+NK1.1
+ DC subsets. Further
staining with anti- CD19, -CD3 and -F4/80 mAbs demonstrated
that the resulting CD11c
+NK1.1
2 DC were negative for B cell, T
cell and macrophage markers (Fig. 1B).
We next investigated whether repeated immunizations of
C57BL/6 mice with Pbc2 spz led to the accumulation/expansion
of the CD11c
+NK1.1
2DC populations in the liver. IHMNC were
analyzed at baseline (naı ¨ve) and after each immunization for the
presence of CD11c
+NK1.1
2 DC. Consistent with another
published study [29], liver CD11c
+NK1.1
2 DC represented
0.0260.019% (0.06610
4 cells) of the total IHMNC in naı ¨ve mice
(Fig. 1C and D). Priming with Pb c2 spz increased the level of
CD11c
+NK1.1
2 DC to 0.0460.02% (0.14610
4 cells) of the total
IHMNC; further increases up to 0.0960.03% (0.75610
4 cells) and
0.1560.04% (1.23610
4 cells) were observed after the first and
second boost immunizations, respectively (Fig. 1C, D and Table 1).
Prime and boost immunizations with uninfected mosquito debris
(sham) resulted but in a negligible increase of CD11c
+NK1.1
2 DC
in comparison to naı ¨ve CD11C
+NK1.1
2DC (Fig. 1C, D). Clearly,
a population of CD11c
+NK1.1
2 DC that was nearly absent in the
livers of naı ¨ve mice accumulated during the course of repeated
immunizations with Pb c2 spz.
Although hepatocytes serve as the primary venue for pre-
erythrocytic stage development and replication of the mammalian
Plasmodia spp, sporozoites also pass through the spleen. To
determine whether multiple immunizations with Pb c2 spz might
have caused an accumulation of DC in the spleen, we examined
splenic cells at the same time points as IHMNC for the presence of
CD11c
+NK1.1
2 DC. We detected CD11c
+NK1.1
2 DC in naı ¨ve
spleens; however, they did not undergo any significant expansion
during repeated immunizations with Pb c2 spz (Fig. 2 B, C).
The increase in liver CD11c
+NK1.1
2 DC during
immunization with Pb c2spz coincides with the
activation of liver CD8
+ T cells
Although we previously documented the presence of CD8
+TEM
(CD44
hiCD45RB
loCD62L
lo) and CD8
+ TCM (CD44
hiCD45RB-
hiCD62L
int ) cells in the livers of mice immunized with Pb c2spz
[12,30], we repeated these analyses along with that of liver DC to
determine whether the induction of the liver CD8
+ T cells was
linked to the emergence of hepatic CD11c
+NK1.1
2 DC. As
shown previously [12,30], ,1% of CD8
+ TEM cells was detected
in the livers of naı ¨ve mice. Six days after priming, liver CD8
+ TEM
cells increased significantly to 6.960.9% (1.4610
5 cells; p=0.001)
and subsequently, six days after the second and third immuniza-
tions, to 17.861.9% (5.2610
5 cells; p=0.0001) and to 35.861.4%
(11.1610
5 cells; p=0.0001), respectively (Fig. 1E and F). Liver
CD8
+ TEM cells increased negligibly (up to 3%) after the third
immunization with uninfected mosquito debris (sham) (Fig. 1E and
F). Liver CD8
+ TCM cells also increased following immunization
with Pb c2spz, but because CD8
+ TCM were already present at an
elevated level (,10%) in the livers of naı ¨ve mice, the only
significant expansion was seen after the first immunization when
the levels increased to ,40% (p=0.005) (Fig. 1E). Collectively,
these results show that the expansion of liver CD8
+ TEM cells in
particular was concurrent with the accumulation of
CD11c
+NK1.1
2 DC in the livers of Pb c2spz-immunized mice,
thus implying a key role for CD11c
+NK1.1
2 DC in the
presentation of liver-stage Ags to liver CD8
+ T cells that mediate
protection induced by Pb c-spz.
Overall, the percentages of CD8
+ TEM cells in the spleens were
lower than those in the livers of the Pb c2spz immunized mice and
similar to our previously published studies [12,30], we observed no
significant accumulation of CD8
+ TEM cells in the spleens of the
mice after repeated immunizations with Pb c2spz. (Fig. 2D, E).
These observations strengthen our hypothesis that the presence of
CD11c
+NK1.1
2 DC in the liver was coincident with the
activation of liver CD8
+ TEM and TCM cells after immunization
with Pb c2spz.
cCD8a
+ DC numbers are low in the livers of naı ¨ve mice
but increase following immunization with Pb c-spz
It has been reported that splenic and liver DC represent
heterogeneous populations [31,32] and based on the expression of
cell surface markers they are divided into three major subsets:
cCD8a
+ DC and cCD8a
2 DC as well as pDC. Moreover, these
cCD8a
+ DC Induce CD8
+T Cells
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cells [33,34]. There is abundant evidence especially from studies of
immune responses to viral infections [2] that cCD8a
+ DC are the
main APC responsible for cross-priming of CD8
+ T cells.
Similarly, liver cCD8a
+ DC have been shown to produce pro-
inflammatory cytokines and prime peptide-specific CD8
+ T cells
during Salmonella infection [35]. Therefore, we asked whether
cCD8a
+DC were present in the expanded population of
CD11c
+NK1.1
2 DC that accumulated in the livers of Pb c-spz
immunized mice. The CD11c
+NK1.1
2 DC were gated as
described in Fig. 1A and then evaluated for the presence of
CD8a
+B220
2 (cCD8a
+DC), CD8a
2B220
2 (cCD8a
2DC) and
CD8a
2B220
+ (pDC) (Fig. 3A).
Cytospin preparations of the purified DC subpopulations were
stained with Giemsa and examined by microscopy. cCD8a
+DC
possessed an abundant cytoplasm and displayed the characteristic
dendrites whereas cCD8a
2DC were characterized by an abun-
dant cytoplasm and an irregular surface. Plasmacytoid DC
displayed a round, smooth surface and an oval nucleus (Fig. 3B).
The relative percentages of cCD8a
+DC were determined in
naı ¨ve mice and in Pb c-spz immunized mice 6 days after each
successive immunization. As can be seen from Fig. 3C, cCD8a
+
DC represented 0.860.3% of the CD11c
+NK1.1
2 population in
naı ¨ve mice. After priming, we observed an increase of up to
5.464.7%; subsequently, after the second and third immuniza-
tions with Pb c-spz the cells remained relatively stable at
5.162.0% and 7.461.9%, respectively. The same trend was
observed when we considered the total number of cCD8a
+ DC
(Table 1). The percentage of cCD8a
+ DC following three
immunizations with mosquito debris (sham) was only slightly
elevated in comparison to naı ¨ve control mice and did not exceed
1.560.8% of the CD11c
+NK1.1
2 cells (p=0.3). Parallel analysis
Figure 1. Both CD11c
+NK1.1
2 DC and CD8
+ TEM cells (CD44
hiCD45RB
lo) accumulate in the livers of Pb c2spz-immunized mice. (A)
HMNC were identified by FSC/SSC and after exclusion of CD3/CD8b
+ T cells, CD11c
+ cells are segregated into CD11c
+NK1.1
+ and CD11c
+NK1.1
2
populations. (B) Dot plots show the level or absence of B cells, T cells and macrophages within the gated CD11c
+NK1.1
2 population. (C) HMNC were
isolated from individual C57BL/6 mice before and after prime and boost immunizations with Pb c2spz or uninfected mosquito debris (sham). Cells
were stained with a cocktail of mAbs and analyzed by flow cytometry for identification of CD11c
+NK1.1
2 DC and CD8
+ TEM. Panels show
representative contour plots of CD11c
+NK1.1
2 DC in the livers of naı ¨ve mice and livers of mice 6 days after the primary (1u), secondary (2u) and
tertiary (3u) immunizations. The percentages of the CD11c
+NK1.1
2 DC in relation to the total HMNC/liver for each representative mouse are indicated
in each panel. (D) The results show the mean %6SD of CD11c
+NK1.1
2 DC in total HMNC of naı ¨ve, Pb c2spz-immunized and sham-immunized mice.
(E) Panels show representative contour plots of CD8
+ TCM cells (CD44
hiCD45RB
hi ) and CD8
+ TEM cells (CD44
hiCD45RB
lo) in the livers of naı ¨ve, Pb
c2spz-immunized and sham-immunized mice at the time-points indicated in (C). The percentages of the CD8+ TEM and CD8+ TCM cells in relation to
the gated liver CD3
+CD8
+ T cells are indicated in the panels. (F) The results show the mean %6SD of CD8
+ TEM in the gated liver CD3
+CD8
+ T cells in
naı ¨ve, Pb c2spz-immunized and sham-immunized mice. The results are representative of three individual mice per group from three independent
experiments.
doi:10.1371/journal.pone.0005075.g001
cCD8a
+ DC Induce CD8
+T Cells
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+NK1.1
2 DC showed the presence of cCD8a
+
DC at 4.4%60.5% in naı ¨ve mice; after priming there was an
increase up to 10.263.2%, but the levels remained relatively
constant at 9.660.2% and 10.161.9% of the CD11c
+NK1.1
2
DC following the second and the third immunizations, (Fig. 3D).
Similar trends were observed with respect to total numbers of
splenic DCs (Table 2). There was no increase in the percentage of
cCD8a
2 DC in either the liver or spleen following immunization
with Pb c-spz (Fig. 3E and F).
To confirm that the liver cCD8a
+ DC induced following
immunization with Pb c-spz were not CD8
+ T cells that have lost
or down-regulated the CD3 marker, we subjected the purified liver
cCD8a
+ DC (Materials and Methods) to two separate analyses: (1)
flow cytometry for both surface and intracellular expression of
CD3, CD8b and CD11c and (2) quantitative RT- PCR for the
presence of CD8b mRNA. According to the flow cytometry
results, liver cCD8a
+ DC were .97% pure (Fig. 4A) and this
population was negative for CD8b mRNA when assayed at 1 cell
per well. (Fig. 4B). These observations not only confirm that the
cCD8a
+ DC is a subset of the liver CD11c
+NK1.1
2DC, but they
demonstrate a significant accumulation of cCD8a
+ DC in the
livers of Pbc-spz-immunized mice (Fig. 3C). We also characterized
the liver cCD8a
+DC for the expression of CD205, MHC and co-
stimulatory molecules as they have been shown [36] to be
expressed on this subset of DC.We found that indeed cCD8a
+ DC
expressed higher levels of CD205 than CD8a
2DC (MFI=252 vs
MFI=166, respectively). The cCD8a
+ DC also exhibited high
expression of MHC class I (MFI=11610
3) and class II
(MFI=14610
3) and moderate levels of CD40 (MFI=545),
CD80 (MFI=667) and CD86 (MFI=512) (Fig. 4C).
Figure 2. CD11c
+NK1.1
2 DC are constitutively present in the spleens of naı ¨ve mice but do not substantially increase following
immunization. (A) CD11c
+NK1.1
2DC in Pbc2spz-immune splenic MNC were identified according to the procedure described for HMNC in Fig 1.
After exclusion of T cells, CD11c
+ cells were segregated into CD11c
+NK1.1
+ and CD11c
+NK1.1
2 populations. Splenic mononuclear cells were isolated
from individual mice before and after prime and boost immunizations with Pbc2spz or uninfected mosquito debris (sham). Cells were stained with a
cocktail of mAbs and NK1.1
2 DC and CD8
+ TEM cells were identified by flow cytometry. (B) Panels show representative contour plots of DC in the
spleens of naı ¨ve mice and in spleens of mice 6 days after either the 1u,2 u and 3u immunizations and in sham-immunized mice 6 days after the 3u
immunization. The percentages of the CD11c
+NK1.1
2 DC in relation to the total SMNC/spleen for each representative mouse are indicated in each
panel. (C) The results show the mean percentage 6SD of CD11c
+NK1.1
2 DC in total spleens of naı ¨ve mice, Pb c2spz-immunized mice at day 6 after
each immunization and in sham-immunized mice at day 6 after the 3u immunization. (D) Panels show representative contour plots of CD8
+ TCM cells
and CD8
+ TEM cells in the spleens of naı ¨ve mice as well as of Pb c2spz-immunized mice and sham-immunized mice at the same time-points described
in (B). The numbers indicate the percentages of the TCM and TEM cells in the gated splenic CD3
+CD8
+ T cell population. (E) The results show the mean
percentage 6SD of CD8
+TEM in the gated splenic CD3
+CD8
+ T cell population of naı ¨ve and immunized mice at day 6 after each immunization.
Contour plots and bar graphs are representative of three individual mice per group in three independent experiments.
doi:10.1371/journal.pone.0005075.g002
cCD8a
+ DC Induce CD8
+T Cells
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+NK1.1
2 DC and
cCD8a
+DC in naı ¨ve and Pbc-spz-immunized mice
a
Immunization
HMNC
(610
6)
NK1.1
2 DC
(610
4)
cCD8a
+DC
(610
2)
Naı ¨ve 1.80 (0.21) 0.06 (0.04) 0.04 (0.02)
Priming 3.30 (0.58) 0.14 (0.09) 0.56 (0.25)
Priming+1boost 7.60 (1.15) 0.75 (0.29) 3.80 (2.12)
Priming+2 boosts 8.30 (2.08) 1.23 (0.18) 9.32 (4.71)
aIHMNC were isolated from individual C57BL/6 mice before and after prime and
boost immunizations with Pb c2spz. Cells were stained with a cocktail of
mAbs for identification of CD11c
+NK1.1
2 DC and cCD8a
+DC as described in
Materials and Methods and analyzed by flow cytometry. Data represent the
mean6SD of the number of cells of three mice per group and are
representative of three independent experiments.
doi:10.1371/journal.pone.0005075.t001
Figure 3. cCD8a
+ DC, relatively absent in the livers of naı ¨ve mice, are induced after prime-boost immunizations with Pbc-spz. (A)
Hepatic CD11c
+NK1.1
2 DC (see Fig. 1) were stained with Abs specific for B220 and CD8a and analyzed by flow cytometry to reveal 3 subpopulations
of DC . (B) HMNC isolated from livers of Pbc-spz-fully immunized mice 6 days after the 3u immunization were incubated with a cocktail of biotinylated
microbeads to deplete T cells, B cells, NK cells, granulocytes and macrophages as described in Materials and Methods. DC subpopulations were
further isolated from the enriched CD11c
+NK1.1
2 population by positive magnetic selection for cCD8a
+DC and pDC and by negative selection for
CD8a
2DC, as described in Materials and Methods. Panels show photographs at 1006of Giemsa stained cytospins of cCD8a
+DC, cCD8a
2DC and pDC.
(C and E) HMNC and (D and F) splenic MNC were isolated from individual naı ¨ve mice and from individual mice at 6 days after 1u,2 u and 3u
immunizations with Pb c2spz and after 3u immunizations with uninfected mosquito debris (sham). Cells were stained with a cocktail of mAbs for
identification of DC subpopulations as described in (A). Bar graphs show the mean % 6 SD of the cCD8a
+DC (C and D) and cCD8a
2DC (E and F) in
the gated CD11c
+NK1.1
2 cells. Data are representative of three individual mice per group at each time-point in two independent experiments.
doi:10.1371/journal.pone.0005075.g003
Table 2. Numbers of splenic CD11c
+NK1.1
2 DC and
cCD8a
+DC in naı ¨ve and Pbc-spz-immunized mice
a
Immunization
SMNC
(610
6)
NK1.1
2 DC
(610
4)
cCD8a
+DC
(610
3)
Naı ¨ve 77.41 (4.21) 11.32 (1.45) 4.97 (0.44)
Priming 84.67 (5.69) 14.21 (3.51) 13.97 (2.59)
Priming+1 boost 74.33 (6.03) 16.31 (2.60) 15.59 (2.68)
Priming+2 boosts 85.33 (5.69) 15.64 (1.62) 15.51 (1.56)
aSMNC were isolated from individual C57BL/6 mice before and after prime and
boost immunizations with Pb c2spz. Cells were stained with a cocktail of
mAbs for identification of CD11c
+NK1.1
2 DC and cCD8a
+DC as described in
Materials and Methods and analyzed by flow cytometry. Data represent the
mean6SD of the number of cells of three mice per group and are
representative of three independent experiments.
doi:10.1371/journal.pone.0005075.t002
cCD8a
+ DC Induce CD8
+T Cells
PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5075Liver cCD8a
+ DC are the primary inducers of CD8
+ T cell
activation
Results from two preliminary experiments showed that CD8
+ T
cells acquired the CD44
hiCD45RB
lo activation phenotype upon in
vitro and in vivo exposure to CD11c
+NK1.1
2 DC purified from the
livers of Pb c-spz-immunized mice. Because cCD8a
+DC are
considered as the primary APC involved in cross-presentation of
Ags to CD8
+ T cells, we proceeded to test the capacity of liver
cCD8a
+DC from Pb c-spz-immunized mice to serve as APC for
the activation/differentiation of naı ¨ve CD8
+ T cells and, by
extension, to confirm the involvement of DC in the development
of protective immunity. CD11c
+NK1.1
2 DC isolated from pooled
livers were further enriched by magnetic depletion using a cocktail
of mAbs (anti-CD3, -CD19, -F4/80, -NK1.1, -Gr-1). cCD8a
+ DC
and pDC cells within the enriched CD11c
+NK1.1
2 DC were each
obtained by positive selection whereas the cCD8a
2 DC were
obtained by negative selection. The purity of the enriched cCD8a
+
DC ranged between 94–98% based on CD11c, CD8b, CD3 and
NK1.1 expression (Fig. 5A and 6A). The purity of the cCD8a
2
DC and pDC was also .90%. We co-cultured negatively selected
CD8
+ T cells from naı ¨ve mice with either cCD8a
+ DC, cCD8a
2
DC or pDC derived from the livers of mice immunized with Pb c-
spz or mice immunized with Pb c-spz and challenged with
infectious sporozoites and analyzed the CD8
+ T cells on day 4 of
the co-culture for the expression of the CD44
hiCD45RB
loactiva-
tion phenotype. As is evident from the results in Fig. 5B–E,
cCD8a
+ DC derived from the livers of either fully immunized or
fully immunized-challenged mice were 3–4 fold more effective
than cCD8a
2 DC and pDC in inducing CD8
+ T cells to acquire
the CD44
hiCD45RB
lo activation phenotype.
As was shown in Figs. 4, 5A and 6A, approximately 2–5%
CD8
+ T cells were present within the purified cCD8a
+DC
subpopulation. To minimize the potential effect of these
contaminating immune CD8
+ T cells in the co-cultures of naı ¨ve
CD8
+ T cells and cCD8a
+DC, we labeled naı ¨ve CD8
+T cells with
CFSE before adding them to DC. At the conclusion of a 4-day
culture, the CFSE-labeled CD8
+ T cells were analyzed for the
expression of the CD44
hiCD45RB
lo phenotype. The gating
scheme for the analysis of the CFSE-labeled splenic CD3
+CD8
+T
cells is shown in Fig. 6B. Similar to the findings shown in Fig. 5,
these results indicate that cCD8a
+ DC derived from the livers of
fully immunized-challenged mice were 4-fold more effective than
cCD8a
2 DC and pDC in inducing CD8
+ T cells to acquire the
CD44
hiCD45RB
lo phenotype (Fig. 6C and D).
cCD8a
+ DC are the major IL-12 producers following
challenge of Pb c-spz-immunized mice
IL-12 is a key cytokine promoting the activation of CD8
+ T cells
[37], therefore, we evaluated the different liver DC subpopulations
to assess if the superior APC properties of the cCD8a
+ DC might
be related to a greater capacity for producing IL-12. Levels of IL-
12p40 were measured in day 4 supernatants from co-cultures of
naı ¨ve CD8
+ T cells with the three DC subpopulations from fully-
immunized mice (Fig. 5F) and the results revealed that the
cCD8a
+ DC were the highest (.100 pg/ml), the cCD8a
2 DC
were the intermediate (,50 pg/ml) and pDC were the lowest
Figure 4. CD8b mRNA is absent in purified liver cCD8a
+DC. HMNC were pooled from livers of Pbc-spz-fully immunized mice 6 days after the 3u
immunization and were incubated with a cocktail of biotinylated microbeads to deplete T cells, B cells, NK cells, granulocytes and macrophages as
described in Materials and Methods. cCD8a
+DC were further isolated from the enriched CD11c
+NK1.1
2 population by positive magnetic selection as
described in Materials and Methods. Staining with anti-CD8a, CD3, CD8b and CD11c was performed on permeabilized cells to reveal both the surface
and the intracellular presence of these markers. (A) Dot plot show the relative % of T cells (red) and cCD8a
+DC (blue) within the purified cCD8a
+DC
population. (B) Two-step quantitative real-time PCR was performed on RNA isolated from magnetic-bead purified liver cCD8a
+DC (described in A).
Ratio of CD8b/CD8a gene expression was calculated using standard curves for each gene. Measurements were done in duplicates in wells containing
1000, 1, 0.1 cells/well, or non-template control (NTC). Representative results of one out of two experiments are shown. (C) Histogram plots show
expression of DEC 205, I-A
b and costimulatory molecules on the cCD8a
+DC population (black lines). Grey lines represent staining of the isotype
controls.
doi:10.1371/journal.pone.0005075.g004
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any of the culture supernatants (data not shown). It should be
pointed out that PCR analysis of cytokine specific mRNA isolated
from each DC subset confirmed the ELISA results (data not
shown).
We also compared the levels of IL-12p40 and IL-10 in the day-4
supernatants co-cultures of naı ¨ve CD8
+ T cells with the cCD8a
+
DC subpopulations from fully-immunized or fully-immunized and
challenged or naı ¨ve-challenged mice. As shown in Fig. 5G, high
levels of IL-12p40 were detected in the culture supernatants with
cCD8a
+ DC from fully-immunized or from fully-immunized and
challenged mice. In contrast, IL-12p40 was not detected in the
supernatants of co-cultures containing cCD8a
+ DC from naı ¨ve-
challenged mice. IL-10 was not detected in any of the culture
supernatants from any of the groups tested.
Activation of CD8
+ T cells by liver cCD8a
+ DC from Pb
c2spz-immunized mice is MHC class I- and IL-12-
dependent
Ag-specific activation of CD8
+ T cells is mediated via the sine
qua non ligation of the TCR by peptide:MHC class I complexes
and it also requires secondary signals delivered via co-stimulatory
molecules [38] and tertiary signals from cytokines [39]. To test
whether this CD8
+ T cell activation was mediated by the
occupancy of the TCR by MHC:peptide complexes and if it
was also dependent upon IL-12, we established parallel co-cultures
consisting of liver or spleen cCD8a
+ DC from mice fully
immunized with Pb c-spz and liver or splenic CD8
+ T cells from
naı ¨ve mice in the presence or absence of either anti-MHC class I
mAb or anti-IL-12 mAb. After 4 days, the acquisition of the
CD44
hiCD45RB
lo phenotype by CD8
+ T cells was analyzed by
Figure 5. Hepatic cCD8a
+ DC from Pbc-spz-immunized and Pbc-spz-immunized and challenged mice mediate in vitro activation of
naı ¨ve CD8
+ T cells. HMNC were pooled from livers of Pbc-spz-fully immunized mice (n=20) 6 days after the 3u immunization and were incubated
with a cocktail of biotinylated microbeads to deplete T cells, B cells, NK cells, granulocytes and macrophages as described in Materials and Methods.
DC subpopulations were further isolated from the enriched CD11c
+NK1.1
2 population by positive magnetic selection for cCD8a
+DC and pDC and by
negative selection for CD8a
2DC, as described in Materials and Methods. (A) Dot plots show the relative % of T cells and NK1.1 cells within the gated
CD11c
+CD8a
+DC. (B) cCD8a
+ DC, cCD8a
2 DC and pDC were purified from CD11c
+NK1.1
2 DC isolated from pooled livers either 6 days after 3u
immunization or 3 days after the challenge of Pbc-spz-immunized as well as naı ¨ve mice . CD8
+ T cells were isolated from the spleens of naı ¨ve mice
using magnetic beads. Liver DC subpopulations and splenic CD8
+ T cells were co-cultured at a ratio of 1 DC : 2 CD8
+T cells for 4 days. Culture
supernatants were harvested and analyzed for IL-10 and IL-12p40 by ELISA. Cells were harvested, stained with a cocktail of mAbs and the % of
CD3
+CD8
+CD45RB
loCD44
hi cells (CD8
+ TEM) was analyzed by flow cytometry. Results show representative contour plots of CD8
+T cells co-cultured
with cDC and pDC subpopulations from Pb c-spz-immunized-challenged mice. Bar graphs show the mean percentage6SD of CD8
+ TEM in the gated
CD3
+CD8
+ T cell population after co-culture with (C) cCD8a
+ DC, (D) cCD8a
2 DC and (E) pDC each isolated from Pbc-spz-fully-immunized, Pbc-spz-
immunized-challenged and naı ¨ve-challenged mice. The experiments were performed twice yielding similar results. (F) IL-12p40 production in the
culture supernatants of CD8
+ T cells with the liver DC populations from the Pbc-spz-immunized mice. The results expressed as pg/ml (mean6SD)
represent data from two representative experiments. (G) cCD8a
+DC were isolated from pooled livers of Pbc-spz-fully-immunized mice, Pbc-spz-
immunized and challenged mice or naı ¨ve-challenged mice and co-cultured with purified naı ¨ve splenic CD8
+ T cells for 4 days. Supernatants were
harvested and analyzed for IL-12p40 and IL-10 by ELISA.
doi:10.1371/journal.pone.0005075.g005
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for IFN-c.
The APC activity of the liver cCD8a
+ DC from Pb c-spz
immunized mice was markedly superior to that of the same
subpopulation of splenic DC, regardless of the source of naı ¨ve
CD8
+ T cells. Whereas the splenic DC induced approximately 5%
of CD8
+ T cells to express the CD44
hiCD45RB
lo phenotype
(Fig. 7A), the liver DC induced at least 2–3-fold higher percentage
of these cells (Fig. 7B). The same superior APC activity of liver DC
was also indicated by the fact that the level of IFN-c was nearly
three-fold higher (60 pg/ml vs 20 pg/ml) (Fig. 7D) in the
supernatants of co-cultures of CD8
+ T cells and liver cCD8a
+
DC as compared to co-cultures with splenic cCD8a
+ DC (Fig. 7C).
IFNc was not detected in the supernatants when cCD8a
+ DC
from either source were cultured alone (Fig.7 C, D).
The capacity of immune liver cCD8a
+ DC to induce CD8
+ T
cells to acquire an activation phenotype and produce IFN-c was
reduced by nearly 70% in the presence of anti-MHC class I mAb.
Although the inclusion of anti-IL-12 mAb had a somewhat lower
inhibitory effect than anti-MHC class I mAb, it also significantly
diminished both responses (Fig. 7E and F). Addition of both
blocking antibodies to the co-culture abrogated the activation of
CD8
+ T cells by reducing both the numbers of CD44
hiCD45RB
lo
CD8
+ T cells and IFN-c production to nearly control levels
(response with CD8
+ T cells alone), thus suggesting an additive or
even synergistic effect of TCR ligation by MHC class I:peptide
Figure 6. Hepatic cCD8a
+ DC from Pbc-spz-immunized and challenged mice mediate in vitro activation of naı ¨ve CD8
+ T cells. HMNC
were pooled from livers of Pbc-spz-fully immunized and challenged mice (n=18) and were incubated with a cocktail of biotinylated microbeads to
deplete T cells, B cells, NK cells, granulocytes and macrophages as described in Materials and Methods. DC subpopulations were further isolated from
the enriched CD11c
+NK1.1
2 population by positive magnetic selection for cCD8a
+DC and pDC and by negative selection for CD8a
2DC, as described
in Materials and Methods. (A) Dot plots show the relative % of T cells and NK1.1 cells within the purified cCD8a
+DC population. (B) CD8
+ T cells were
isolated from the spleens of naı ¨ve mice using magnetic beads and labeled with 2 mM CFSE. Dot plots show the gating scheme for the analysis of
CFSE-labeled CD3
+CD8
+T cells for expression of the CD45RB
loCD44
hi phenotype. (C) cCD8a
+ DC, cCD8a
2 DC and pDC were purified from
CD11c
+NK1.1
2 DC isolated from pooled livers 3 days after the challenge of Pbc-spz-immunized mice. Liver DC subpopulations and CFSE-labeled
splenic CD8
+ T cells were co-cultured at a ratio of 1 DC : 2 CD8
+T cells for 4 days. Cells were harvested, stained with a cocktail of mAbs and the % of
CD3
+CD8
+CD45RB
loCD44
hi cells (CD8
+ TEM) was analyzed by flow cytometry. Results show contour plots of CD8
+T cells co-cultured with cDC and pDC
subpopulations. (D) Bar graphs show the percentage of CD8
+ TEM in the gated CD3
+CD8
+ T cell population after co-culture with cCD8a
+ DC, cCD8a
2
DC and pDC each isolated from Pbc-spz-immunized-challenged mice.
doi:10.1371/journal.pone.0005075.g006
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+ T
cells by liver cCD8a
+ DC.
Adoptively transferred liver CD11c
+NK1.1
2 DC obtained
from Pb c2spz-immunized mice confer protection
against liver-stage infection
It has been reported that adoptive transfer of bone marrow-
derived DC pulsed with Py CS protein peptide significantly
reduces parasitemia in Balb/c mice challenged with Py sporozoites
[15]. Based on our preliminary observations that liver
CD11c
+NK1.1
2 DC from Pb c-spz immunized mice were able
to activate CD8
+ T cells both in vitro and in vivo (data not shown),
we hypothesized that adoptive transfer of these DC into naı ¨ve
mice might confer protection or at least reduce the level of
parasitemia in sporozoite-challenged recipients. In an initial
experiment, 1610
6 liver CD11c
+NK1.1
2 DC from Pb c-
spz2immunized mice were adoptively transferred (i.v.) into naı ¨ve
recipients and this group as well as a control group not receiving
any DC were subsequently challenged (i.v.) with 10K infectious Pb
sporozoites. The results showed that even though the transferred
hepatic CD11c
+NK1.1
2 DC significantly decreased parasitemia
(Fig. 8A) and prolonged survival following infectious challenge,
they were unable to confer sterile protection. Because 10K
infectious sporozoites constitute a very high challenge dose, we
asked whether protection could be achieved against a lower
challenge dose. Thus, in the next set of experiments
CD11c
+NK1.1
2 DC from the livers of Pb c-spz immunized-
challenged or naı ¨ve-challenged mice were transferred separately
into naı ¨ve recipients that were subsequently challenged with 250
sporozoites. As shown in Fig. 8B, recipients of hepatic
CD11c
+NK1.1
2 DC from Pb c-spz-immunized-challenged mice
were sterilely protected when challenged with 250 infectious
sporozoites. However, protection was lost upon re-challenge at
6 months with 250 infectious sporozoites, implying that sterile
protective immunity induced by the transferred CD11c
+NK1.1
2
DC was short-lived. Notably, hepatic CD11c
+NK1.1
2 DC from
naı ¨ve-challenged mice did not confer protection even against the
low-dose challenge. Collectively, these results strongly support our
contention that liver CD11c
+NK1.1
2 DC are actively involved in
mediating protective immunity induced by Pb c-spz and that their
protective function depends upon their capacity to present Ag to
liver CD8
+ T cells that leads to the induction of effector cells
against infectious sporozoites.
Figure 7. Liver cCD8a
+ DC are more efficient than splenic cCD8a
+ DC in inducing differentiation of and IFN-c production by CD8
+ T
cells. Differentiation and induction of CD8
+ T cell function is MHC class I- and IL-12 dependent. HMNC or splenic MNC were prepared after the 3u
immunization as described in Fig. 3. CD8a
+ DC were purified as described in Figs 1 and 3. Splenic (A and C) or hepatic (B and D) cCD8a
+ DC were co-
cultured for 4 days either alone or with purified CD8
+ T cells from the livers (open bars) or spleen (filled bars) of naı ¨ve mice. Cells were harvested,
stained with the appropriate mAb and analyzed by flow cytometry. Culture supernatants were analyzed for IFNc by ELISA. (A and B) Results show the
mean % of CD8
+ TEM in the gated CD3
+CD8
+ T cell population and (C and D) the amount of IFNc in the culture supernatant. Data are representative of
two individual experiments. (E and F) Liver cCD8a
+ DC were co-cultured with naı ¨ve splenic CD8
+ T cells in the presence or absence of anti-IL-12 (clone
C17.1) and/or anti-MHC class I (clone 28-8-6) mAbs for 4 days. (E) Results show the mean % of CD8
+ TEM in the gated CD3
+CD8
+ T cell population and
(F).the amount of IFNc. Data is representative of two individual experiments.
doi:10.1371/journal.pone.0005075.g007
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In the present study we demonstrated that CD8a
+
CD11c
+NK1.1
2 DC, although infrequent in the livers of naı ¨ve
mice, increased in number in the livers of mice undergoing prime-
boost immunizations with Pb c-spz. The numbers as well as
percentages of the liver cCD8a
+DC increased significantly after
priming and were maintained following boost immunizations, but
declined after challenge with infectious sporozoites. The emer-
gence of liver DC was concurrent with the appearance of hepatic
CD8
+ TEM cells (CD44
hiCD45RB
lo), that in agreement with our
previous findings [12,30], accumulate slowly, with the peak
response occurring only after the 3
rd immunization. This temporal
relationship between the CD11c
+NK1.1
2 DC and CD8
+ T cells
suggests that liver DC serve as key Pb liver-stage Ag-presenting
cells that induce liver CD8
+ T cells to differentiate into the major
effector T cells that confer protection against infectious sporozoite
challenge. This contention is further supported by our demon-
stration that liver cCD8a
+ DC from either Pb c-spz-immunized or
Pb c-spz-immunized-challenged mice induced CD8
+ T cells from
naı ¨ve mice to express the CD44
hiCD45RB
lo activation phenotype
and to produce IFN-c in an in vitro system. Most importantly,
adoptive transfer of purified liver CD11c
+NK1.1
2 DC isolated
from Pb c-spz immunized donors conferred protective immunity
to congenic recipient mice challenged with infectious sporozoites.
Like infectious Plasmodia sporozoites, Pb c-spz also invade
hepatocytes but they undergo developmental arrest at the liver-
stage. The aborted forms of liver-stage parasites are thought to
provide a repository of liver-stage Ags needed for the induction
and the maintenance of sterile and long lasting protective
immunity [28]. However, the mechanisms involved in the
processing of these Ags and their presentation to T cells remain
to be fully elucidated. Recent studies [22,40] suggest that infection
with either Pb c-spz or genetically-attenuated Plasmodia sporozo-
ites causes hepatocytes to undergo apoptosis, a process that is
currently viewed as a potent trigger of host innate and adaptive
immune responses [41,42]. Therefore, it is reasonable to suggest
that the attenuated sporozoite-infected apoptotic hepatocytes
provide a rich repertoire of liver-stage Ags that are taken up by
the liver DC and cross-presented to CD8
+ T cells in the liver.
Numerous studies [2,3,25] have shown that cCD8a
+ DC are the
predominant subpopulation of DC that mediate cross-presentation
of cell-associated bacterial and viral Ags for the activation of CD8
+
T cells. Data from the present study demonstrate for the first time
that cCD8a
+ DC indeed were represented in the hepatic
CD11c
+NK1.1
2 DC of Pb c-spz-immunized mice. Although
nearly absent in the livers of naı ¨ve mice, this subset increased
significantly after the priming dose of Pb c-spz and it was the most
effective APC that induced CD8
+ T cells to both acquire the
CD44
hiCD45RB
lo activation phenotype and to produce IFN-c in
Figure 8. Liver CD11c
+NK1.1
2 cells from Pbc-spz-immunized mice induce protection against infectious sporozoites. (A) 1610
6
CD11c
+NK1.1
2 cells, isolated from the livers of Pbc-spz-fully-immunized mice 6 days after the 3u immunization, were adoptively transferred (i.v.) into
naı ¨ve recipients. Seven days later the adoptively transferred recipients (n=3) as well as naı ¨ve infectivity control mice (n=3) were challenged with 10K
infectious sporozoites. The results show the level of parasitemia assessed in each individual mouse and expressed as the mean of parasitemia per
mice/group at 4, 7 and 10 days following challenge. (B) 1610
6 hepatic CD11c
+NK1.1
2 cells, purified as described in (A) were isolated from Pbc-spz-
immunized-challenged mice and from naı ¨ve-challenged mice and adoptively transferred into naı ¨ve syngeneic recipients (n=13) that were challenged
7 days later with either 250 (n=6) or 1000 (n=7) infectious sporozoites. The protected group (250 sporozoites) were re-challenged 60 days later
along with another group of naı ¨ve infectivity control mice (n=3). Pb c-spz-immunized mice (n=3), used as positive controls, were sterily protected at
challenge and re-challenge. Parasitemia and survival were evaluated from day 2 post-challenge.
doi:10.1371/journal.pone.0005075.g008
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cCD8a
+ DC cross-present P. berghei liver-stage Ags derived from
apoptotic Pb-infected hepatocytes to liver CD8
+T cells.
Based on their percentages and numbers, the cCD8a
+ DC were
not the dominant subset in the livers of Pb c-spz immunized or Pb
c-spz immunized-challenged mice. Nevertheless, the liver cCD8a
+
DC exhibited superior APC activity relative to the other two
subsets of liver DC and to splenic cCD8a
+ DC derived from the
same animals. The splenic cCD8a
+ DC remained at a steady level
(,10%) during the entire prime-boost immunization with Pb c-spz
and their capacity to activate CD8
+ T cells from naı ¨ve mice to
express the CD44
hiCD45Rb
lo phenotype and to produce IFN-c
was 4-fold lower than that of liver cCD8a
+ DC. This dichotomy
between APC activities of liver and spleen cCD8a
+ DC may be
explained by the fact that Pb c-spz primarily invade and undergo a
partial development within hepatocytes. Consequently, the
availability of liver-stage Ags for cross-presentation would likely
be higher in the liver than the spleen. Thus, the site of the
induction of CD8
+ T cells (liver versus spleen) might be related to
the local availability of Ags for presentation to the responding
CD8
+ T cells.
Infectious sporozoites develop into liver merozoites that are
released into the blood stream to infect red blood cells and thus,
initiate clinical malaria. Challenging naive mice with infectious
sporozoites also led to an accumulation of cCD8a
+ DC in the liver;
however the APC activity of these cells was rather ineffective in
comparison to that of liver cCD8a
+ DC from Pbc-spz immunized or
Pbc-spz immunized and challenged mice. Several mechanisms may
be proposed to explain the difference between the two populations of
liver cCD8a
+ DC. First, two recent reports [23,24] showed that, in
contrast to attenuated sporozoites, infectious Pb sporozoites do not
induce infected hepatocytes to undergo apoptosis and hence are able
to complete their differentiation into liver-stage merozoites that are
released into the blood stream without prior alarming or inducing the
immune system. Consequently, there is likely a paucity of available
earlyliver stage Ags in mice with active liver stage infection. Secondly,
our previous results demonstrated that MHC class I molecules are
down-regulated on both Kupffer cells (KC) [43] and liver DC
(unpublished data) 24–48 hrs after the challenge of naive mice. The
decreased intensity of MHC class I on the surface of KC leads to a
diminution in their APC function [43,44]. The reduction of MHC
classIoncCD8a
+DC in infected animals (data not shown) also might
have reduced their capacity to present liver-stage Ag to CD8
+ T cells.
Finally, cCD8a
+ DC from livers of naı ¨ve challenged mice do not
produce detectable levels of IL-12 and this also could have
compromised their capacity to activate CD8
+ T cells. These results
extend the recently published observations that IL-12-producing DC
are found only in mice infected with a non-lethal strain of P. yoelii but
not in mice infected with the lethal strain [45]. It should also be noted
that in contrast to our observations, a recently published study
showed that human pDC that produce IFN-a following viral
infection also were able to cross-prime CD8
+ T cells [46].
DC-mediated differentiation of Ag-specific CD8
+ T cells
involves the requisite signal 1 delivered through the ligation of
the TCR by peptide-MHC class I complexes as well as the
necessary provision of co-stimulation (signal 2) and pro-inflam-
matory cytokines such as IL-12 (signal 3). Although the
characterization of Pb liver-stage Ags is in progress, the exact
nature of these Ags is currently unknown. Consequently, we were
unable to use defined tetramers or transgenic CD8
+ T cells to
verify the Pb Ag specificity of the Pb c-spz-immune-CD8
+ T cells.
However, the Ag-specificity of the responding CD8
+ T cells is
strongly implied by the observation that IFN-c production and the
expression of the CD44
hiCD45RB
lo on CD8+ T cells were
abrogated by nearly 70% by anti-MHC class I mAb. The
importance of this finding is supported by the fact that MHC class
I KO mice are not protected by immunization with Pb c-spz when
exposed to a high challenge dose [27]. It has also been shown
previously [38] that the activation of CD8
+ T cells and
polarization toward Th1 activity is dependent on IL-12 as it
induces T cell expansion and is required for IFN-c production. In
the present study, an essential role for IL-12 in the DC-mediated
activation of hepatic CD8
+ T cells is suggested by the fact that the
hepatic cCD8a
+ DC were the main producers of IL-12. Moreover,
anti-IL-12 antibody inhibited both the in vitro induced expression
of the CD44
hiCD45RB
lo activation phenotype on CD8
+ T cells
and IFN-c production in co-cultures of CD8
+ T cells and cCD8a
+
DC. The additive/synergistic inhibitory activities of the anti-MHC
class-I and anti-IL-12 antibodies indicate that both MHC class
I:peptide-complexes and IL-12 were required for the activation of
the hepatic CD8
+ T cells by cCD8a
+ DC. Our observations are
firmly supported by many previous findings demonstrating the
importance of IL-12 in protection against malaria liver-stage
infection via its ability to directly induce IFN-c production
necessary for protection against liver-stage infection [47,48,49].
It is now well accepted that protective immunity induced by
attenuated Plasmodia sporozoites is multi-factorial involving
antibodies, CD4
+ T cells as well as other lymphocytes, but that
the CD8
+ T cells are the main effectors against pre-erythrocytic
infection. An essential question remains, therefore, whether the
activation of liver-stage Ag-specific CD8
+ T cells by DC occurs in
the liver or in an immune organ, such as the draining celiac LN,
after which the effector CD8
+ T cells are recruited to the liver.
Although our study addressed neither the issue of CD11c
+NK1.1
2
DC migration into the liver from other tissues nor their potential
differentiation from cells such as CD11c
+NK1.1
+ DC that are
constitutively present in the livers of naı ¨ve mice [50], nonetheless
such discussion is warranted in order to reach a better understand-
ing of the individual immune events and their integration into the
overall mechanisms that culminate in protective immunity.
According to evidence from studies of immune responses
elicited by model protein Ags, viral and microbial Ags as well as
from studies of responses to Plasmodia Ags, three different
scenarios can be considered: (1) DC acquire and present parasite
Ag to CD8
+ T cells in the draining LN and subsequently the CD8
+
T cells migrate to the liver; (2) DC acquire parasite Ags in the liver
after which they migrate to the LN to activate CD8
+ T cells and
then both cells migrate back to liver; and (3) CD8
+ T cell:DC
interactions occur exclusively in the liver, where DC cross-present
liver stage Ag to liver CD8
+ T cells.
According to the first scenario, immature celiac LN DC with
enhanced capacity for Ag uptake, encounter Plasmodia Ags,
including those associated with sporozoites that are en route to
invade the liver. Among the available Ag for uptake by DC, the
CS protein might be the primary candidate as it readily sloughs off
but is also quickly replaced on sporozoites. Although uptake of
other candidate Plasmodia Ags is quite possible, priming of CD8
+
T cells specific for Py CS protein has recently been observed in the
draining LN after vaccination with Py c-spz [16]. Following Ag
uptake, the DC mature and activate LN CD8
+ T cells that then
migrate to the liver to perform their effector function during
infection. Although our observation of the late emergence of
CD44
hiCD45RB
lo CD8
+ T cells in the liver could be accommo-
dated by this scenario, the incompatibility lies with the Ag
specificity as liver CD8
+ T cells do not recognize peptides from Pb
CS protein (Krzych U, unpublished data). Other sporozoite or
early liver-stage Ag specificities are possible, but they have not
been tested.
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take up liver-stage Ag from the apoptotic hepatocytes invaded by
Pb c-spz. The Ag-loaded and matured DC then migrate to the
liver draining LN, where they engage in the induction of CD8
+ T
cells that subsequently migrate to the liver during infection to
perform the effector function. In support of this scenario,
influenza-specific CD8+T cells that have been activated in the
LN perform optimal effector function only in the presence of Ag-
loaded DC in the lung [51]. Although quite attractive, it has been
shown that migratory DC do not normally express the CD8a
+
phenotype [52] and the cCD8a
+ DC were the major activators of
CD8
+ T cells in our system. In addition, according to the results
from a preliminary study, the draining LN contains a very small
proportion of activated CD8
+ T cells following i.d. or i.v.
immunizations with Pb c-spz.
The third model proposes that cross presentation of the aborted
liver-stage Ags by liver DC and the subsequent activation of liver
CD8
+ T cells occurs uniquely in the liver. The possibility of the
local activation of CD8
+ T cells by liver-stage Ag is quite attractive
for several reasons, but especially because it enables a rapid
response in the event of parasite invasion of the liver that occurs
within 2 mins following i.v. challenge [53]. Furthermore, although
activated CD8
+ T cells home from other regions of the body to the
liver where they become eliminated as a way of purging their
destructive effector mechanism [54], there is also evidence from
other studies showing that direct activation of naı ¨ve CD8
+ T cells
can indeed occur in the liver [55,56,57]. The accumulation of
CD11c
+NK1.1
2 DC in the liver could be explained on the basis of
an inflammatory response, i.e., production of IL-12 by KC shortly
after priming with Pb c-spz [43]. Others have also shown that
recruitment of DC to the liver is mediated by soluble factors such
as MIP-1a and IL-12, possibly released from KC as DC
recruitment is absent in KC cell-depleted animals [58]. KC also
trap and maintain DC in the liver via selective adhesion involving
N-acetylgalactosamine-mediated interactions [59]. The co-pres-
ence of cCD8a
+ DC and CD8
+ T cells in the liver and the
proximity of liver-stage Ags from the apoptotic Pb c-spz invaded
hepatocytes provide all the necessary elements for the initiation of
adoptive immune responses in a non-lymphoid organ that is the
venue for infection with Plasmodia parasites.
Materials and Methods
Mice
Female C57BL/6 mice (6–8 weeks old) were purchased from
The Jackson Laboratory (Bar Harbor, ME) and were housed at the
Walter Reed Army Institute of Research (WRAIR) animal facility
and handled according to institutional guidelines. All procedures
were reviewed and approved by the Animal Care and Use
Committee of the institute and were performed in a facility
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International.
Sporozoites, immunizations and parasitemia
Pb sporozoites were isolated from mosquitoes as described
previously [12] Sporozoites were attenuated by exposure to 15,000
rad of c-radiation (Cesium-137 source Mark 1 series or Cobalt-60
Model 109; JL Shepard & Associates, San Fernando, CA). As
previously described [12,30], mice were primed i.v. with 75K
Pbc2spz followed by two i.v. boost immunizations of 20K
Pbc2spz administered 1 week apart. Control mice were primed
and boosted with material from sham dissected mosquitoes that
represented an equivalent number of infected mosquitoes. For
challenge experiments, mice were infected i.v. with a low dose of
either 250 or 1000 infectious sporozoites or a high dose of 10, 000
infectious sporozoites approximately one week after the last boost
immunization. Thin blood smears were prepared from individual
mice starting on day 2 after the challenge and the percentage of
parasitized red blood cells was determined microscopically.
Antibodies
The following mAbs anti-NK1.1 FITC, NK1.1 PE, CD40
FITC, CD80 FITC, CD86 FITC, H-2K
b FITC, I-A
b FITC,
DEC-205 FITC (Serotec, Raleigh, NC.), CD45RB FITC, CD44
PE, B220/CD45RB PE, B220/CD45RB PerCP, CD8a PerCP,
CD8a Pacific Orange (Caltag, Burlingame, CA.), CD11c APC,
CD3 biotin, CD3e PE, CD3e Pacific Blue (eBioscience, San
Diego, CA.), CD8b PE, CD19 biotin, CD19 PE, CD11c biotin,
Gr-1 FITC, F4/80 PerCP (Biolegend, San Diego, CA.), F4/80
biotin, Gr-1 biotin, NK1.1 biotin, CD16/CD32 (Fc block),
purified anti-IL12p40 (C17.8), purified anti-mouse H-2K
b/H-
2D
b (28-8-6) and isotype controls and anti-biotin microbeads
(Miltenyi Biotec, Auburn, CA.) were (unless stated otherwise)
obtained from (BD Pharmingen, San Diego, CA)
Isolation of IHMC
Mice were euthanized by CO2 inhalation. Livers were exposed
and the inferior vena cava was cut for blood outflow. The livers
were perfused with 10ml PBS [32], removed and pressed through
a7 0mM nylon cell strainer (BD Labware, Franklin Lakes, NJ) and
the liver cell suspension was processed as previously described
[12,30]. Briefly, the liver cells were washed 16 in PBS,
resuspended in PBS containing 35% Percoll (Amersham Pharma-
cia Biotec, Uppsala, Sweden) and centrifuged at 2,000 rpm for
20 min. Erythrocytes in the cell pellet were lysed with RBC lysis
buffer (Sigma, St. Louis, MO) and the remaining hepatic
mononuclear cells (HMNC) were washed and resuspended in
complete RPMI 1640 medium.
Isolation of hepatic CD11c
+NK1.1
2 DC
CD11c
+NK1.1
2 cells were isolated as previously described [2].
Briefly, HMNC were incubated with a cocktail of biotinylated
(anti-CD3e, CD19, NK1.1, Gr-1, F4/80) mAb for 15 minutes at
4uC. Following washing in buffer (PBS containing 2mM EDTA
and 0.5% BSA), the cells were magnetically labeled with anti-
biotin microbeads for 15 minutes at 4uC. The CD11c
+ cells were
enriched by negative isolation on a MS column (Miltenyi Biotec)
according to the manufacturer’s instructions. The purity and
viability of the enriched CD11c
+NK1.1
2 preparation were
assessed by flow cytometry and trypan blue exclusion,.and were
found to be ,94% and .96% respectively.
Isolation of CD11c
+NK1.1
2 DC subpopulations
For isolation of cCD8a
+ DC or pDC, enriched hepatic
CD11c
+NK1.1
2 cells were labeled with CD8a (Ly-2) microbeads
or CD45R (B220) microbeads and the labeled cells isolated by
positive selection on MS columns. For isolation of cCD8a
2DC,
CD11c
+NK1.1
2 cells were labeled with a cocktail of CD8a (Ly-2)
and CD45R (B220) microbeads and isolated by negative selection
on MS columns. The purity of the DC subpopulations was .95%
and viability was .97%.
RT-PCR
Total RNA was extracted from purified splenic CD8
+T cells and
purified liver CD8a
+CD11c
+ cells using an RNeasy Plus Mini Kit
(Qiagen, Valencia, CA) and treated with DNase. RNA concentration
and quality control were determined by UV spectrophotometry and
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synthesized from total RNA using High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA) according to
the manufacturer’s instructions. The qPCR for CD8a chain mRNA
and CD8b chain mRNA was performed using SuperArray’s RT
2
Real-Time SYBR Green/Rox PCR master kit, CD8a
(PPM04031A), CD8b1 (PPM04032E) primer mixes, and Applied
Biosystems 7500 Fast Real-Time PCR System. The temperature
profile was 10 min at 95uC followed by 40 cycles of (95uC, 15 sec;
60uC, 60 sec). Melting curve analysis was performed after qPCR for
quality control purposes.
Flow cytometry
For evaluation of T cell activation, four-color staining of HMNC
and splenic MNC was performed using a combination of the
following mAb: FITC-anti-CD45RB (16A), PE-anti-CD3 (17A2),
PerCP-anti-CD8a (53-6.7), and APC-anti-CD44 (IM7). For
identification of CD11c
+NK1.1
2 DC; HMNC and splenic MNC
were stained using a combination of the following mAb: FITC-anti-
NK1.1 (PK136), PE-anti-CD3e (17A2), PE-anti-CD8b (53-5.8),
PerCP-anti-CD45R/B220 (RA3-6B2), Pacific Orange-anti-CD8a,
and APC-anti-CD11c (HL3). For evaluation of DEC-205, MHC
and costimulatory molecules, HMNC were analyzed using a
combination of the following mAb: FITC-anti-DEC-205 (NLDC-
145), FITC-anti-CD40, FITC-anti-CD80 (16-10A1), FITC-anti-
CD86 (GL-2), FITC-anti-IA
b (AF6-120.1), FITC-anti H-2K
b, PE-
anti-CD3e, PE-anti-CD8b, PerCP-anti-CD45R/B220, Pacific
Orange-anti-CD8a, and APC-anti-CD11c. For evaluation of the
purity of the CD11c
+CD8a
+ cells, the positively isolated cells were
stained using a combination of the following mAb: FITC-anti-
NK1.1,PE-anti-CD11c,PerCP-anti-CD19,PacificBlue-anti-CD3e
and Pacific Orange-anti-CD8a. Briefly, 2–10610
5 cells were
resuspended in cold assay buffer (PBS containing 1% BSA (Sigma)
and 0.01% sodium azide) and incubated with anti-FcR 24G2 and
0.5 mg of the relevant mAb at 4uC for 30 min. Cells were washed
and resuspended in cold assay buffer. Flow cytometry analyses of T
cells and of DC were performed on a FACSCalibur (BD
Biosciences) and an LSRII (BD Biosciences) flow cytometer,
respectively. Data analysis was performed using FlowJo 8.1.0
software (Tree Star, Inc., Ashland, OR).
In vitro cultures
CD11c
+NK1.1
2 DC (5610
5) or purified DC subpopulations
(5610
5) from livers or spleens of Pbc-spz-immunized mice were co-
cultured with naı ¨ve hepatic or splenic CD8
+ T cells (1610
6)i na
1ml volume of complete culture media (RPMI 1640 supplemented
with 10% heat-inactivated FCS, 10mM Hepes, 100U of penicillin,
100 mg of streptomycin and 4mM L-glutamine) in a 48-well tissue
culture plate for 4 days. A ratio of 1:2 of hepatic DC:CD8
+ T cells
yielded the highest percentage of recovered viable CD8
+ T cells
and was used in all experiments. For blocking experiments,
antibodies against lL-12p40 (clone C17.8) and H-2K
b/H-2D
b
(clone 28-8-6) were used at 5 mg/ml. Cells and culture
supernatants were harvested at day 4 for determination of CD8
+
T cell activation and cytokine production, respectively.
CFSE labeling
Purified splenic CD8
+ T cells were incubated with 2 mM CFSE
(Molecular Probes – Invitrogen, Eugene, OR.) for 7 min at room
temperature. Cells were washed three times with 10ml complete
culture medium. After the final wash, the cells were resuspended in
complete culture medium and viability was .98%. 1610
6 CFSE-
labeled splenic CD8+T cells were co-cultured with 5610
5 purified
cCD8a
+DC, cCD8a
2DC and pDC isolated from livers of Pbc-
spz-immunized-challenged mice in a 1ml volume of complete
culture media in a 48-well tissue culture plate for 4 days. Cells
were harvested, washed and stained with PE-anti-CD45RB (16A),
PerCP-anti-CD3 (17A2), APC-anti-CD44 (IM7) and Pacific
Orange-anti-CD8a for evaluation of T cell activation.
Morphology
Freshly purified hepatic cCD8a
+DC, cCD8a
2DC and pDC
were cytospun onto glass slides (1 min at 1000rpm) and fixed in
methanol for 15 min at room temperature. Slides were stained
with Giemsa (Sigma Diagnostics, St Louis, MO) for 20 min and
photographed.
IL-10 and IL-12p40 determination
The presence of IL-10 and IL-12p40 were determined using IL-
10 and IL-12p40 ELISA kits (BD Biosciences, San Diego, CA)
according to the manufacturer’s instructions.
IFN-c Determination
IFN-c was determined using an R&D ELISA kit (R&D
Systems, Minneapolis, MN) and according to the manufacturer’s
instructions.
Adoptive transfer
To evaluate the protective effect of hepatic DC against liver-stage
infection, purified CD11c
+NK1.1
2 DC (1610
6) from livers of Pb
c2spz-immunized mice were transferred (i.v.) into naı ¨ve C57BL/6
mice. Seven days after the adoptive transfer, recipient mice were
challenged with 250 or 1000 infectious sporozoites. Parasitemia and
survival were evaluated from day 2 post-challenge.
Statistical Analysis
Data are presented as the means6SD, and the differences
among groups were analyzed by the Mann-Whitney U test using
the Graphpad Prism software. A value of p,0.05 was considered
significant.
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